← Back to directory

Jacques Genest

Researcher Next ID · RN-028434

Researcher · Medicine

McGill University Health Centre

Montreal, Canada

Not currently recruitingFunding unknown
Works count
964
Citation count
72,076
H-index
105
i10-index
546

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lipoproteins and Cardiovascular Health
Hormonal Regulation and Hypertension
Diabetes, Cardiovascular Risks, and Lipoproteins
Cholesterol and Lipid Metabolism
Cancer, Lipids, and Metabolism

Publications

  • 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults

    Canadian Journal of Cardiology · 2021 · https://doi.org/10.1016/j.cjca.2021.03.016

  • Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease

    Circulation · 2020 · 10.1161/circulationaha.119.044795

  • Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

    Atherosclerosis · 2018 · 10.1016/j.atherosclerosis.2018.07.014

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1707914

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32814-3

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32247-x

  • Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

    The Lancet Diabetes & Endocrinology · 2016 · 10.1016/s2213-8587(16)30041-9

  • 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    Canadian Journal of Cardiology · 2016 · https://doi.org/10.1016/j.cjca.2016.07.510

  • 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    Canadian Journal of Cardiology · 2013 · 10.1016/j.cjca.2012.11.032

  • The Metabolic Syndrome and Cardiovascular Risk

    Journal of the American College of Cardiology · 2010 · https://doi.org/10.1016/j.jacc.2010.05.034

  • 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

    Canadian Journal of Cardiology · 2009 · 10.1016/s0828-282x(09)70715-9

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Obstetrical & Gynecological Survey · 2009 · https://doi.org/10.1097/01.ogx.0000344393.60303.0a

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

    The Lancet · 2009 · 10.1016/s0140-6736(09)60447-5

  • A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0900241

  • Stress Pathways to Spontaneous Preterm Birth: The Role of Stressors, Psychological Distress, and Stress Hormones

    American Journal of Epidemiology · 2009 · 10.1093/aje/kwp061

  • Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

    New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0807646

  • Socio‐economic disparities in preterm birth: causal pathways and mechanisms

    Paediatric and Perinatal Epidemiology · 2001 · 10.1046/j.1365-3016.2001.00012.x

  • Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence

    Annals of Internal Medicine · 1999 · 10.7326/0003-4819-131-5-199909070-00008

  • Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

    Nature Genetics · 1999 · https://doi.org/10.1038/11905

  • Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux

    The Lancet · 1999 · 10.1016/s0140-6736(99)07026-9

  • Low density lipoprotein particle size and coronary artery disease.

    Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1992 · 10.1161/01.atv.12.2.187

  • Familial lipoprotein disorders in patients with premature coronary artery disease.

    Circulation · 1992 · 10.1161/01.cir.85.6.2025

  • The Heart and the Atrial Natriuretic Factor*

    Endocrine Reviews · 1985 · 10.1210/edrv-6-2-107

  • Effect of native and synthetic atrial natriuretic factor on cyclic GMP

    Biochemical and Biophysical Research Communications · 1984 · 10.1016/0006-291x(84)90260-2

  • NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS.

    PubMed · 1964

Current projects

    No projects listed.